Novo Nordisk's GLP-1 for Type II diabetes approved for first-line treatment
Roche searches for pharma chief Anderson's successor from within
Novavax CEO Erck bids adieu after 12 years
Three TIGIT players look to surprise in 2023
*please scroll down for all the latest news*
